CompletedPhase 2NCT02061384
RA-2 13-cis Retinoic Acid (Isotretinoin)
Studying Male infertility due to gonadal dysgenesis or sperm disorder
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Washington
- Principal Investigator
- John K Amory, MD, MPHUniversity of Washington
- Intervention
- 13-cis retinoic acid(drug)
- Enrollment
- 20 enrolled
- Eligibility
- 21-60 years · MALE
- Timeline
- 2014 – 2018
Study locations (1)
- University of Washington Medical Center, Seattle, Washington, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02061384 on ClinicalTrials.gov